Importantly, we also performed a meta-analysis, exploiting the Kaplan–Meier Plotter (https://kmplot.com/analysis/); this is a large public database containing gene expression datasets from cancer populations with associated clinical data [23], that was used to investigate how PARP12 gene expression affected the survival of breast cancer patients. This evidence concerns the gene PARP12 and breast carcinoma.